SEC Form D private-offering filing
OS Therapies Inc
A new SEC Form D private-offering notice from Grasonville, MD, a $9,250,000 filer-stated offering target in Biotech. The source filing is one click away.
Clinical stage biopharmaceutical company developing immunotherapies for osteosarcoma and other HER2 expressing solid tumors.
Filed 6 days agoFiled to raise $9,250,000First money in 2026-06-30Raised so far $1,600,000HQ (as filed) Grasonville, MDSector Biotech ✓Stage (inferred) EarlyCall status Call-ready
Source linked the Form D on EDGAR↗Website verified ostherapies.com↗Named in the filing 8 executives & directors
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.